logo
'Patients snarl like dogs': The horrifying reality of dying from rabies - as Yorkshire grandmother dies from disease

'Patients snarl like dogs': The horrifying reality of dying from rabies - as Yorkshire grandmother dies from disease

Daily Mail​13 hours ago

Health chiefs today sounded the alarm after a British woman died of rabies, contracting the fatal disease from a scratch by a stray puppy in Morocco.
Grandmother Yvonne Ford, 59, from Barnsley, South Yorkshire, became ill two weeks ago and steadily deteriorated until her death this week.
Her daughter, Robyn Thomson, 32, a neo-natal nurse, paid tribute to her mother—known as 'Bon'—in a moving post, and urged others to treat even the tiniest scratch with caution.
Rabies, which is passed on through injuries such as bites and scratches from an infected animal, is nearly always fatal.
After an infection, the symptoms can take up to a year to appear.
But when they do appear, the disease is a swift and brutal killer. Most patients die in a few days.
Research has even suggested people can lose 'bodily control and rationality', with historical records showing some who contracted rabies from dog bites 'snarled like dogs' and 'barked'.
Here MailOnline reveals exactly how the dangerous illness takes hold.
Initial symptoms may appear similar to the flu, with later signs including a fever, headache, nausea, agitation, difficulty swallowing and excessive saliva.
But as it travels through the nerves and spinal cord up to the brain—through the central nervous system— inflammation of the brain or brain swelling, develops.
Jeanna Giese, now 35, is the first person known to have survived rabies without receiving the rabies vaccine—a feat considered impossible before her case in 2004.
She was bitten by a bat at the age of 15, before suddenly developing symptoms three weeks later.
Speaking to the Guardian in 2023, she said: 'I started feeling unbelievably tired.
'A few days after that, I could not get out of bed, had double vision and was vomiting uncontrollably. Soon I became unresponsive.'
It was only by receiving a novel treatment called the Milwaukee Protocol, that she survived.
This involved doctors putting her into an induced coma to suppress brain function and prevent the deadly build-up of inflammation by giving her antiviral drugs.
After two weeks she was taken out of the coma and spent the following two years in recovery where she learned to walk and talk again.
Others, however, have not been so lucky and suffer hallucinations or even paralysis once the virus takes hold.
According to the World Health Organization (WHO), paralytic rabies accounts for around a fifth of all human cases.
Muscles gradually become paralysed, starting at the site of the bite or scratch. A coma slowly develops and eventually death occurs.
Last year, Brazilian health officials also reported that a man had died from rabies after the disease left him with fatal brain inflammation.
The 56-year-old was bitten by a monkey and three weeks later began to experience vomiting, drooling and fainting.
Within a week, he was diagnosed with encephalitis—meaning his brain had swelled and despite treatment, died a fortnight later.
Writing in The Conversation, one Canadian historian also told how patients with rabies historically also lost 'bodily control and rationality'.
Professor Jessica Wang, an expert in US history at the University of British Columbia, said 19th century newspapers 'frequently described those who contracted rabies from dog bites as barking and snarling like dogs, while cat-bite victims scratched and spat'.
Hallucinations, 'respiratory spasms and out-of-control convulsions' were also common symptoms recorded, she added.
It comes as UK health officials today revealed a British woman has died of rabies after contracting the fatal disease in a scratch from a stray puppy in Morocco.
In a separate Facebook post, her daughter Robyn Thomson said: 'Our family is still processing this unimaginable loss, but we are choosing to speak up in the hope of preventing this from happening to others.
'Yvonne Ford, Ron Ford's wife and our Mum, died of rabies. She was scratched very slightly by a puppy in Morocco in February.
'At the time, she did not think any harm would come of it and didn't think much of it.
'Two weeks ago she became ill, starting with a headache and resulted in her losing her ability to walk, talk, sleep, swallow. Resulting in her passing.'
She added: 'We never thought something like this could happen to someone we love. Please take animal bites seriously, vaccinate your pets, and educate those around you.
'She was the heart of our family—strong, loving, and endlessly supportive. No words can fully capture the depth of our loss or the impact she had on all of us.
'We are heartbroken, but also grateful for every moment we had with her. Rest peacefully, Bon. You'll always be with us.'
It is understood Ms Ford was diagnosed with the disease at Barnsley Hospital.
An inquest into her death opened this morning at 9am at Sheffield Coroners' Court, which her daughter attended. It has since been adjourned.
There have been less than 10 cases of human rabies associated with animal exposures abroad reported in the UK since 2000.
However, the UKHSA today stressed there was 'no risk to the wider public' given there is 'no documented evidence of rabies passing between people'.
The last death caused by rabies in a UK animal—other than bats—was in 1902.
Dog licensing, euthanasia of stray dog and quarantining were credited with killing off the virus.
Western Europe is now considered low risk for the disease by the WHO, while countries in Eastern Europe are listed as 'moderate risk' and African and Middle Eastern countries are 'high risk'.
Popular tourist destinations like Egypt, Tunisia, Morocco and Turkey all carry a high risk of dogs transmitting rabies to people.
Dr Katherine Russell, head of emerging infections and zoonoses, at the UKHSA said: 'I would like to extend my condolences to this individual's family at this time.
'If you are bitten, scratched or licked by an animal in a country where rabies is found then you should wash the wound or site of exposure with plenty of soap and water and seek medical advice without delay in order to get post-exposure treatment to prevent rabies.
'There is no risk to the wider public in relation to this case.
'Human cases of rabies are extremely rare in the UK, and worldwide there are no documented instances of direct human to human transmission.'
Today, it is possible to save a patient who has contracted rabies if they can begin treatment before the virus enters their immune system.
The course of treatment for rabies is four doses of the vaccination for rabies and human rabies immunoglobulin (antibodies) applied over a 21-day period.
The last recorded rabies death in the UK was in 2018, when Omar Zouhri, a 58-year-old kebab shop worker, was bitten by a cat while visiting family in Mehdya, Morocco.
An inquest in Oxford heard that Mr Zouhri had contracted rabies on August 31 2018, but it was not until as late as October 28 that 'the die was cast' when he started to report symptoms of 'furious rabies'.
This included itching, pain and muscle twitches—which showed the virus had already entered his central nervous system, rendering treatment ineffective.
Mr Zouhri, from Aylesbury in Buckinghamshire, died in hospital in Oxford on November 4, 2018.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Southampton lung expert warns indoor air pollution is being overlooked
Southampton lung expert warns indoor air pollution is being overlooked

BBC News

timean hour ago

  • BBC News

Southampton lung expert warns indoor air pollution is being overlooked

A leading respiratory expert has warned the dangers of indoor air pollution are being respiratory physician Dr Thom Daniels, from University Hospital Southampton (UHS), says the "invisible threat" may pose an even bigger risk to health than outdoor can trigger short-term respiratory symptoms and make existing conditions such as asthma warning comes as the Royal College of Physicians (RCP) publishes a new report linking air pollution to 30,000 deaths a year in the UK. "We know so much more about outdoor air pollution because it's so much easier to study," says Dr Daniels. "One monitor allows you to know about the air quality for thousands of people. But every single house is different and we spend 90% of our time indoors and until we understand better about indoor air quality, we'll be missing the majority of our air exposure." Particulates and harmful gases come from daily activities within the home such as cooking or using wood burning and other household cleaning products can also add to the problem. People with chronic lung conditions are advised to limit their use where possible."Burning your cooking on your hob really produces a lot of the very small material, particulate matter," continues Dr Daniels."Dust is unavoidable, there's always going to be dust. Cleaning products produce chemicals in the air."And another area that is really important is wood burning stoves. Everyone loves a wood burning stove - it's so lovely - but it really does produce a lot of indoor air pollution as well as outdoor." To understand how indoor air quality can be affected by everyday household tasks, I've borrowed an air monitor from Dr app tells me the air outside is good quality scoring 97 out of a possible 100. The higher the number the less measurable pollution is start with my indoor reading is about the same but it does not take long for things to go a piece of salmon, I light a fragranced candle to disguise the smell. A bit of vacuuming and spraying down the kitchen counter are also on the chores but surely the air quality starts to fall. Without burning the food it is down to 49 out of 100 - telling me the air quality is house just smells of cooking. I've never before thought of it as poor air quality. How low can you go? Curious to see what the monitor would show I decide to put two slices of bread into the toaster and crank it long whisps of smoke begin to fill the kitchen and the air quality is not long before the smoke alarm sounds and the smell of burned toast fills the entire indoor air monitor now reads zero, warning of severe pollution and telling me patients and members of sensitive groups may have to take emergency action. While poor air quality in the home is linked to household activities, which are usually short term, there is concern spikes in indoor air pollution could still be harmful."We do know that these spikes can induce changes in our bodies - so inflammation in the airways, in the cells of our airways and damage to the integrity of those airways to prevent other things getting in," warns Dr there is action you can take to reduce the levels of indoor pollution in your recommend always using an extractor fan when cooking and using the rear of the hob so that fumes go up the wall into the fan rather than towards the only dry, untreated wood at a high temperature will also help reduce emissions from wood the meantime, Dr Daniels is calling for more research into indoor air pollution to understand the problem we are all living with. You can follow BBC Hampshire & Isle of Wight on Facebook, X (Twitter), or Instagram.

Dudley MP proud to lead first incontinence debate in Commons
Dudley MP proud to lead first incontinence debate in Commons

BBC News

timean hour ago

  • BBC News

Dudley MP proud to lead first incontinence debate in Commons

A Labour MP has said she is proud to be leading a debate about incontinence that is the first of its kind in the House of Kumar, MP for Dudley, will chair the backbench business committee debate on Thursday, which will shine a light on the issues faced by those with pelvic health issues. Kumar said the issue "affected millions across the UK", however it remained "overlooked and under-discussed". She hoped the debate would help to bring incontinence "out of the shadows" and give it the "attention it deserves". The National Institute for Health and Care estimates that 34% of women had urinary Dudley MP, who is a physiotherapist, said she had worked closely with women to help them manage the challenges of pelvic floor had previously spoken about pelvic health during a Westminster debate on women's health and received a "wave of responses" from people who had similar experiences."These are not just medical conditions, they are deeply personal challenges that can significantly impact individuals' dignity, independence, and mental wellbeing," Kumar said. Mum-of-four Leanne Shakespeare, 51, said she experienced incontinence for nearly 30 years after she had a breach birth. "I have to wear towels when I leave the house, I'd love to go swimming again but I can't. "When I'm on holiday I couldn't take my shorts off or go in the water."Ms Shakespeare, who is from Kingswinford, said it had impacted her confidence and mental health. She added that it had taken her 10 years to tell anyone what she had experienced."It's a taboo and it isn't talked about enough, now I just have to get on with it and try not to let it stop me."Ms Shakespeare said the debate was a "great idea" and she planned to "follow it on TV". Polly Weston, co-chair of the Association for Continence Professionals, was pleased that the issue had "finally gained traction". "The government is talking about something that the nation is secretly trying to deal with", she said."People will quite happily talk about other medical problems, but the minute you talk about your bowels or bladder, it doesn't seem to be a conversation." Ms Weston said she had spoken to cancer patients who found it "more complex" to talk about their bladder and bowels than the treatment they had received. She added that the privacy towards incontinence was "culture and learnt behaviour" and called for health professionals to "ask patients more open questions" about the issue. Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.

How do the new antibody drugs for Alzheimer's disease work?
How do the new antibody drugs for Alzheimer's disease work?

The Independent

timean hour ago

  • The Independent

How do the new antibody drugs for Alzheimer's disease work?

Two new drugs for Alzheimer's have been rejected for use on the NHS. They slow progression of the disease, but they can have serious side-effects. – What are the medicines? Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer's. They represent a huge step forward in research because they target a known cause of the disease, rather than just treating the symptoms. Both drugs bind to amyloid, a protein which builds up in the brains of people living with Alzheimer's disease. By binding to amyloid, the drugs are designed to help clear the build-up and slow down cognitive decline. – How effective are they? Donanemab has been shown in clinical trials to slow the rate at which memory and thinking get worse by more than 20%. Evidence suggests that people get the most benefit if they are given the treatment earlier in the disease. Results also suggest the drug leads to a 40% slowing in the decline of everyday activities such as driving, enjoying hobbies and managing money. Lecanemab has also been shown to successfully remove protein build-up from the brains of people living with early Alzheimer's disease. For people taking lecanemab, this meant the decline in their thinking and memory skills was slowed down by 27%. It also slowed down the decline in quality of life by up to 56%. – How are the drugs given? Donanemab, developed by the pharmaceutical company Lilly, is given to patients via an intravenous drip once every four weeks. Lecanemab, developed by Eisai, is also given this way but fortnightly. – Are there any side-effects? Side-effects of the drugs can be serious and people undergo monitoring to check for them. In one clinical trial published in the Journal of the American Medical Association (JAMA) in 2023, 24% of people receiving donanemab had side-effects including brain swelling and infusion-related reactions. Four people died during the trial, with their deaths thought to be related to the drug's side-effects. Lecanemab resulted in infusion-related reactions in around 26% of people on the trial and followed up, while 14% suffered amyloid-related imaging abnormalities causing brain swelling. Others suffered minor bleeds picked up on scans. Around one in 10 people suffered headaches, according to updated results published in May 2024. Overall, four deaths during the follow-up period were thought to be due to treatment. – How much do the drugs cost? NHS England published a briefing paper last year suggesting the cost of bringing the drugs to the health service could be £500 million to £1 billion per year. Around 50%-60% of the total estimated cost relates to the drug price, with remaining cash spent on patient assessment, diagnosis and administering the treatment. – How many people in England might the drugs have worked for? NHS England estimated between 50,000 and 280,000 patients could be eligible for the new treatments if they were approved for the NHS. To get the drugs, patients need a baseline MRI scan and then either a PET-CT scan or lumbar puncture to confirm Alzheimer's. It is possible that blood tests will be available in the future to diagnose the disease, so NHS England did warn there should be caution about driving a 'massive expansion' in other diagnostics which could become redundant in the longer term. -What do scientists think? Scientists and doctors have been divided on whether the drugs represent a real clinical benefit that is noticeable in patients day-to-day. Some argue the drugs represent a huge advance and people should be given the chance to try them. But others say the benefits are too small. Jennifer Keen, associate director of evidence, policy and influencing at the Alzheimer's Society, has said: 'we remain at an important and exciting moment', adding: 'There are currently 182 active clinical trials for Alzheimer's disease… We are on the cusp of major scientific breakthroughs beginning to improve the outlook for those with the disease.' Professor Rob Howard, from University College London, said: 'Nobody should be surprised that Nice have confirmed their earlier view that the new Alzheimer's disease treatments would not be cost-effective if used within the NHS. 'Well-conducted clinical trials demonstrated that the actual size of benefits experienced by patients were too small to be noticeable, treatment carries risks of side-effects, and the annual cost of the drugs and safety monitoring required would have been close to the cost of a nurse's salary for each treated patient. We need better treatments that can make an appreciable difference to the lives of people with dementia and these can only come from further research and study.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store